Hopefully these financings will indeed mean that the kidney trial for those on dialysis and the Fabrys trial will get underway shortly. Some more strings on the RVX bow would be nice.

Would be interesting to know what the “security documentation” entails, ie what is the security. This should satisfy the TSX review and with a much clearer financial path to BETOnMACE completion hopefully the stock price will start to move towards the Beacon number, probably discounted at least somewhat by the security arrangement. In any event, this time around we will hopefully know what the fate of BETOnMACE is before the loan expires  All in all probably a great deal given RVX’s current situation IMO.